{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:45:30Z","timestamp":1786545930977,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/ajg.2014.26","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T09:01:41Z","timestamp":1395133301000},"page":"535-541","source":"Crossref","is-referenced-by-count":74,"title":["A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial"],"prefix":"10.14309","volume":"109","author":[{"given":"Liya","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infectionthe Maastricht IVFlorence Consensus Report.","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"R2-17-20210210","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"R3-17-20210210","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection.","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R4-17-20210210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance.","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"R5-17-20210210","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"},{"key":"R6-17-20210210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-148-12-200806170-00226","article-title":"Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.","volume":"148","author":"Jafri","year":"2008","journal-title":"Ann Intern Med"},{"key":"R7-17-20210210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MCG.0b013e3181d7a16c","article-title":"Sequential or concomitant therapy for Helicobacter pylori eradication?","volume":"44","author":"Gisbert","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R9-17-20210210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2036.2003.01461.x","article-title":"High eradication rates of Helicobacter pylori with a new sequential treatment.","volume":"17","author":"Zullo","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-17-20210210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-146-8-200704170-00006","article-title":"Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.","volume":"146","author":"Vaira","year":"2007","journal-title":"Ann Intern Med"},{"key":"R11-17-20210210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1155\/2006\/258768","article-title":"Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.","volume":"20","author":"Scaccianoce","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"R12-17-20210210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MCG.0b013e3181acebef","article-title":"Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability.","volume":"44","author":"Paoluzi","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R13-17-20210210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2036.2004.01818.x","article-title":"Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.","volume":"19","author":"De Francesco","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R14-17-20210210","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1365-2036.2010.04274.x","article-title":"Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.","volume":"31","author":"Molina-Infante","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-17-20210210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1440-1746.2011.06922.x","article-title":"Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.","volume":"27","author":"Oh","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-17-20210210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","article-title":"14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.","volume":"378","author":"Greenberg","year":"2011","journal-title":"Lancet"},{"key":"R17-17-20210210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"key":"R18-17-20210210","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/gut.2010.215350","article-title":"Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.","volume":"59","author":"Romano","year":"2010","journal-title":"Gut"},{"key":"R19-17-20210210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ajg.2009.708","article-title":"Ten-day sequential therapy of Helicobacter pylori infection in Thailand.","volume":"105","author":"Sirimontaporn","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R21-17-20210210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1440-1746.2011.06660.x","article-title":"Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test.","volume":"26","author":"Mahachai","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R22-17-20210210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1440-1746.2011.06885.x","article-title":"Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.","volume":"27","author":"Tsay","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R23-17-20210210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1751-2980.2012.00575.x","article-title":"Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.","volume":"13","author":"Huang","year":"2012","journal-title":"J Dig Dis"},{"key":"R24-17-20210210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1523-5378.2012.00947.x","article-title":"Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.","volume":"17","author":"Molina-Infante","year":"2012","journal-title":"Helicobacter"},{"key":"R25-17-20210210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1440-1746.2012.07249.x","article-title":"Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.","volume":"27","author":"Chung","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R26-17-20210210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1440-1746.2009.06188.x","article-title":"Epidemiology of Helicobacter pylori infection and gastric cancer in Asia.","volume":"25","author":"Fock","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R27-17-20210210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1523-5378.2011.00856.x","article-title":"Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children.","volume":"16","author":"Liu","year":"2011","journal-title":"Helicobacter"},{"key":"R28-17-20210210","first-page":"S10","article-title":"Working Party of the European Helicobacter pylori Study Group.","volume":"41","year":"1997","journal-title":"Gut"},{"key":"R29-17-20210210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1523-5378.2011.00890.x","article-title":"Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view.","volume":"16","author":"Calvet","year":"2011","journal-title":"Helicobacter"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg201426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201426","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201404000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:48:57Z","timestamp":1786542537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201404000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2014.26","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}